Finance

Lists
ASTRAZEN:NSE
Astrazeneca Pharma India Ltd
₹7,500.00
-1.90%
(-145.00) 1D
Aug 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ASTRAZEN...
Open
₹7,680.00
High
₹7,738.50
Low
₹7,481.00
Mkt. cap
187.50B
Avg. vol.
0.00
Volume
53.65K
Dividend
0.48%
Quarterly dividend
₹9.00
Ex-dividend date
Jul 31, 2026
P/E ratio
110.54
52-wk high
₹9,849.50
52-wk low
₹7,481.00
EPS
₹67.85
Shares outstanding
25.00M
No. of employees
760
Open
₹7,680.00
High
₹7,738.50
Low
₹7,481.00
Mkt. cap
187.50B
Avg. vol.
0.00
Volume
53.65K
Dividend
0.48%
Quarterly dividend
₹9.00
Ex-dividend date
Jul 31, 2026
P/E ratio
110.54
52-wk high
₹9,849.50
52-wk low
₹7,481.00
EPS
₹67.85
Shares outstanding
25.00M
No. of employees
760
About Astrazeneca Pharma India Ltd
CEO-
Employees760
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
6.83B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.59B
6.12B
5.79B
6.83B
Cost of goods sold
3.24B
3.66B
3.98B
4.47B
Cost of revenue
3.24B
3.66B
3.98B
4.47B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
884.60M
1.30B
-392.20M
1.10B
Operating expense
1.62B
2.04B
1.25B
1.92B
Total operating expenses
4.86B
5.71B
5.23B
6.39B
Operating income
726.10M
409.90M
556.00M
437.10M
Other non operating income
61.70M
51.30M
-175.20M
92.30M
EBT including unusual items
728.20M
465.40M
581.40M
507.50M
EBT excluding unusual items
781.10M
450.60M
593.50M
509.90M
Income tax expense
186.00M
139.50M
132.60M
128.20M
Effective tax rate
25.54%
29.97%
22.81%
25.26%
Other operating expenses
655.10M
694.70M
1.49B
741.30M
Net income
542.20M
325.90M
448.80M
379.30M
Net profit margin
9.70%
5.33%
7.76%
5.56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
232.00M
-
Interest expense
-6.70M
-10.60M
-20.40M
-19.50M
Net interest expenses
-6.70M
-10.60M
211.60M
-19.50M
Depreciation and amortization charges
25.70M
38.40M
56.00M
52.30M
EBITDA
821.80M
493.98M
598.30M
479.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps